As an industry, the pharmaceutical segment has contributed over MYR6 billion toward Malaysia’s gross domestic product (GDP). By 2024, the industry will potentially contribute another MYR10 billion.
Currently, there are more than 445 pharmaceutical companies with a total market value of MYR7.5 billion (2018) invested in two categories of products which span across the healthcare supply chain in Malaysia and representing professionals from many fields.
PhAMA members also engage in ethical and economic social responsibility. Member companies contribute more than MYR42 million annually to continuing medical education (CMEs) to enhance knowledge and skills of healthcare professionals. Additionally, PhAMA members operate ten global and regional shared service centres in Malaysia, contributing towards the country's move towards a high-knowledge economy.
(Source: IQVIA)